Barrot Lambdin

Title(s)Assistant Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address3333 California Street, #001
San Francisco CA 94118
vCardDownload vCard

    Collapse Overview 
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Optimizing Overdose Education and Naloxone Distribution Delivery in the United States
    NIH R21DA046703Sep 30, 2018 - Aug 31, 2021
    Role: Principal Investigator
    Preventing Opioid Overdose Mortality in the United States
    NIH R01DA046867Jul 15, 2018 - May 31, 2021
    Role: Principal Investigator
    Reducing Failure-to-Initiate ART among People Who Inject Drugs: the IMAT Strategy
    NIH R34DA037787Jun 1, 2014 - May 31, 2018
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon. JAMA Netw Open. 2024 Sep 03; 7(9):e2431612. Zoorob MJ, Park JN, Kral AH, Lambdin BH, Del Pozo B. PMID: 39235814; PMCID: PMC11378001.
      View in: PubMed   Mentions:
    2. Racialized environments and syringe services program implementation: County-level factors. Drug Alcohol Depend. 2024 Aug 28; 263:112430. Bluthenthal RN, Humphrey JL, Strack CN, Wenger LD, LaKosky P, Patel SV, Kral AH, Lambdin B. PMID: 39216198.
      View in: PubMed   Mentions:
    3. Comparing harm reduction and overdose response services between community-based and public health department syringe service programmes using a national cross-sectional survey. Lancet Reg Health Am. 2024 Jun; 34:100757. Ray BR, Humphrey JL, Patel SV, Akiba CF, Bluthenthal RN, Tookes H, LaKosky PA, Wenger LD, Kral AH, Lambdin BH. PMID: 38745887; PMCID: PMC11091529.
      View in: PubMed   Mentions:
    4. Funding and Delivery of Syringe Services Programs in the United States, 2022. Am J Public Health. 2024 04; 114(4):435-443. Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, Bluthenthal RN, LaKosky P, Prohaska S, Morris T, Kral AH, Lambdin BH. PMID: 38478864; PMCID: PMC10937606.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    5. Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes. SSM Qual Res Health. 2024 Jun; 5. Akiba CF, Smith J, Wenger LD, Morris T, Patel SV, Bluthenthal RN, Tookes HE, LaKosky P, Kral AH, Lambdin BH. PMID: 38957482; PMCID: PMC11218888.
      View in: PubMed   Mentions:
    6. Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California. Int J Drug Policy. 2024 Apr; 126:104366. Wenger LD, Morris T, Knight KR, Megerian CE, Davidson PJ, Suen LW, Majano V, Lambdin BH, Kral AH. PMID: 38492432; PMCID: PMC11160962.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Adapting a health facility HIV stigma-reduction participatory training intervention to address drug use stigma in HIV care and treatment clinics in Dar es Salaam, Tanzania. Harm Reduct J. 2024 Mar 15; 21(1):65. Mlunde LB, Saalim K, Mbwambo JK, Kiwia P, Fitch E, Manyama W, Rugemalila I, Clay S, Lambdin BH, Stelmach RD, Bann C, Nyblade L. PMID: 38491349; PMCID: PMC10941424.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial. Implement Sci. 2024 Feb 28; 19(1):22. Lambdin BH, Bluthenthal RN, Garner BR, Wenger LD, Browne EN, Morris T, Ongais L, Megerian CE, Kral AH. PMID: 38419058; PMCID: PMC10900734.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda. Addict Sci Clin Pract. 2024 02 23; 19(1):13. Kamusiime B, Beima-Sofie K, Chhun N, Nalumansi A, Nalukwago GK, Kasiita V, Twesige CC, Kansiime R, Muwonge TR, Kyambadde P, Kadama H, Mudiope P, Glick S, Lambdin B, Mujugira A, Heffron R. PMID: 38395940; PMCID: PMC10893723.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020. Int J Drug Policy. 2024 Jan; 123:104289. Tookes HE, Bartholomew TS, Sugar SES, Plesons MD, Bluthenthal RN, Wenger LD, Patel SV, Kral AH, Lambdin BH. PMID: 38071932; PMCID: PMC10878422.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Health risks associated with smoking versus injecting fentanyl among people who use drugs in California. Drug Alcohol Depend. 2024 Feb 01; 255:111053. Megerian CE, Bair L, Smith J, Browne EN, Wenger LD, Guzman L, Kral AH, Lambdin BH. PMID: 38128362.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment. Int J Drug Policy. 2023 Nov; 121:104214. Suen LW, Steiger S, Shapiro B, Castellanos S, Joshi N, Lambdin BH, Knight KR. PMID: 37778132.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Impact of a high-volume overdose prevention site on social and drug disorder in surrounding areas in San Francisco. Drug Alcohol Depend. 2023 11 01; 252:110969. Davidson PJ, Wenger LD, Morris T, Majano V, Browne EN, Lambdin BH, Suen LW, Kral AH. PMID: 37748424.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency. Harm Reduct J. 2023 09 02; 20(1):122. Bartholomew TS, Tookes HE, Chueng TA, Bluthenthal RN, Wenger LD, Kral AH, Lambdin BH. PMID: 37660029; PMCID: PMC10475193.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    15. Evaluating oxygen monitoring and administration during overdose responses at a sanctioned overdose prevention site in San Francisco, California: A mixed-methods study. Int J Drug Policy. 2023 Nov; 121:104165. Suen LW, Wenger LD, Morris T, Majano V, Davidson PJ, Browne EN, Ray B, Megerian CE, Lambdin BH, Kral AH. PMID: 37652815.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: study protocol of a randomized controlled trial. Implement Sci. 2023 08 03; 18(1):33. Akiba CF, Patel SV, Wenger LD, Morgan-Lopez A, Zarkin GA, Orme S, Davidson PJ, Kral AH, Lambdin BH. PMID: 37537665; PMCID: PMC10398915.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    17. 'New evidence' for Syringe Services Programs? A call for rigor and skepticism. Int J Drug Policy. 2023 Nov; 121:104107. Lambdin BH, Bluthenthal RN, Humphrey JL, LaKosky P, Prohaska S, Kral AH. PMID: 37996217.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. "All carrots and no stick": Perceived impacts, changes in practices, and attitudes among law enforcement following drug decriminalization in Oregon State, USA. Int J Drug Policy. 2023 08; 118:104100. Smiley-McDonald HM, Attaway PR, Wenger LD, Greenwell K, Lambdin BH, Kral AH. PMID: 37356287.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    19. Correction: The Systems Analysis and Improvement Approach: specifying core components of an implementation strategy to optimize care cascades in public health. Implement Sci Commun. 2023 Mar 27; 4(1):33. Gimbel S, Ásbjörnsdóttir K, Banek K, Borges M, Crocker J, Coutinho J, Cumbe V, Dinis A, Eastment M, Gaitho D, Lambdin BH, Pope S, Uetela O, Hazim C, McClelland RS, Mocumbi AO, Muanido A, Nduati R, Njuguna IN, Wagenaar BH, Wagner A, Wanje G, Sherr K. PMID: 36973763; PMCID: PMC10041789.
      View in: PubMed   Mentions:
    20. Spatiotemporal Trends in Three Smoothed Overdose Death Rates in US Counties, 2012-2020. Prev Chronic Dis. 2023 03 23; 20:E16. Saunders ME, Humphrey JL, Lambdin BH. PMID: 36952675; PMCID: PMC10038091.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs. BMC Health Serv Res. 2023 Mar 22; 23(1):278. Patel SV, Wenger LD, Kral AH, Sherr K, Wagner AD, Davidson PJ, Lambdin BH. PMID: 36949494; PMCID: PMC10035142.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study. Harm Reduct J. 2023 02 28; 20(1):26. Lambdin BH, Wenger L, Bluthenthal R, Bartholomew TS, Tookes HE, LaKosky P, O'Neill S, Kral AH. PMID: 36855181; PMCID: PMC9972698.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. The Systems Analysis and Improvement Approach: specifying core components of an implementation strategy to optimize care cascades in public health. Implement Sci Commun. 2023 Feb 14; 4(1):15. Gimbel S, Ásbjörnsdóttir K, Banek K, Borges M, Crocker J, Coutinho J, Cumbe V, Dinis A, Eastment M, Gaitho D, Lambdin BH, Pope S, Uetela O, Hazim C, McClelland RS, Mocumbi AO, Muanido A, Nduati R, Njuguna IN, Wagenaar BH, Wagner A, Wanje G, Sherr K. PMID: 36788577; PMCID: PMC9926643.
      View in: PubMed   Mentions: 3  
    24. Accelerating Solutions for the Overdose Crisis: an Effectiveness-Implementation Hybrid Protocol for the HEAL Prevention Cooperative. Prev Sci. 2023 Oct; 24(Suppl 1):40-49. Patel SV, Cance JD, Bonar EE, Carter PM, Dickerson DL, Fiellin LE, Fernandes CSF, Palimaru AI, Boomer TMP, Saldana L, Singh RR, Tinius E, Walton MA, Youn S, Young S, Philbrick S, Lambdin BH. PMID: 36399222; PMCID: PMC9673891.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Prevalence and factors associated with neck injection among people who inject drugs in San Francisco, California. Drug Alcohol Depend. 2022 Dec 01; 241:109686. Duhart Clarke SE, Megerian CE, Suen LW, Wenger LD, Lambdin BH, Davidson PJ, Kral AH. PMID: 36402050.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs. Subst Abuse Treat Prev Policy. 2022 07 15; 17(1):51. Lambdin BH, Kan D, Kral AH. PMID: 35841036; PMCID: PMC9283820.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    27. Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach. Harm Reduct J. 2022 05 28; 19(1):55. Wenger LD, Doe-Simkins M, Wheeler E, Ongais L, Morris T, Bluthenthal RN, Kral AH, Lambdin BH. PMID: 35643444; PMCID: PMC9145109.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States. Drug Alcohol Depend. 2022 08 01; 237:109504. Lambdin BH, Bluthenthal RN, Tookes HE, Wenger L, Morris T, LaKosky P, Kral AH. PMID: 35688052; PMCID: PMC10878423.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    29. Establishment and Enforcement of Operational Rules at an Unsanctioned Safe Drug Consumption Site in the United States, 2014-2020. Am J Public Health. 2022 04; 112(S2):S166-S172. Davidson PJ, Wenger LD, Lambdin BH, Kral AH. PMID: 35349308; PMCID: PMC8965194.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    30. Effect of an Unsanctioned Safe Consumption Site in the United States on Syringe Sharing, Rushed Injections, and Isolated Injection Drug Use: A Longitudinal Cohort Analysis. J Acquir Immune Defic Syndr. 2022 02 01; 89(2):172-177. Suen LW, Davidson PJ, Browne EN, Lambdin BH, Wenger LD, Kral AH. PMID: 34723925.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States. J Gen Intern Med. 2022 11; 37(15):3853-3860. Lambdin BH, Davidson PJ, Browne EN, Suen LW, Wenger LD, Kral AH. PMID: 35020166; PMCID: PMC8753940.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Improved syringe disposal practices associated with unsanctioned safe consumption site use: A cohort study of people who inject drugs in the United States. Drug Alcohol Depend. 2021 12 01; 229(Pt A):109075. Kral AH, Lambdin BH, Wenger LD, Browne EN, Suen LW, Davidson PJ. PMID: 34654588.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Transition from injecting opioids to smoking fentanyl in San Francisco, California. Drug Alcohol Depend. 2021 10 01; 227:109003. Kral AH, Lambdin BH, Browne EN, Wenger LD, Bluthenthal RN, Zibbell JE, Davidson PJ. PMID: 34482046; PMCID: PMC10790652.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    34. Bridging institutional logics: Implementing naloxone distribution for people exiting jail in three California counties. Soc Sci Med. 2021 09; 285:114293. Showalter D, Wenger LD, Lambdin BH, Wheeler E, Binswanger I, Kral AH. PMID: 34388622.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA. Drug Alcohol Depend. 2021 08 01; 225:108759. Kinnard EN, Bluthenthal RN, Kral AH, Wenger LD, Lambdin BH. PMID: 34058540.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    36. Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises. Transl Res. 2021 08; 234:159-173. Wenger LD, Kral AH, Bluthenthal RN, Morris T, Ongais L, Lambdin BH. PMID: 33746108; PMCID: PMC8217165.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    37. Impact of an unsanctioned safe consumption site on criminal activity, 2010-2019. Drug Alcohol Depend. 2021 03 01; 220:108521. Davidson PJ, Lambdin BH, Browne EN, Wenger LD, Kral AH. PMID: 33485010.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    38. Law enforcement identification of potential trafficking victims. Journal of Crime and Justice. 2020 Nov 7; 1-16. Barrick BK, Panichelli PM, Lambdin LB, Dang DM, Lutnick LA. .
      View in: Publisher Site   Mentions:
    39. Overdose Education and Naloxone Distribution Within Syringe Service Programs - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Aug 21; 69(33):1117-1121. Lambdin BH, Bluthenthal RN, Wenger LD, Wheeler E, Garner B, Lakosky P, Kral AH. PMID: 32817603; PMCID: PMC7439981.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    40. Evaluation of an Unsanctioned Safe Consumption Site in the United States. N Engl J Med. 2020 08 06; 383(6):589-590. Kral AH, Lambdin BH, Wenger LD, Davidson PJ. PMID: 32640126.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    41. Cascade Analysis: An Adaptable Implementation Strategy Across HIV and Non-HIV Delivery Platforms. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S322-S331. Wagner AD, Gimbel S, Ásbjörnsdóttir KH, Cherutich P, Coutinho J, Crocker J, Cruz E, Cuembelo F, Cumbe V, Eastment M, Einberg J, Floriano F, Gaitho D, Guthrie BL, John-Stewart G, Kral AH, Lambdin BH, Liu S, Maina M, Manaca N, Matsuzaki M, Mattox L, Mburu N, McClelland RS, Micek MA, Mocumbi AO, Muanido A, Nduati R, Njuguna IN, Oluoch G, Oyiengo LB, Ronen K, Soi C, Wagenaar BH, Wanje G, Wenger LD, Sherr K. PMID: 31764270; PMCID: PMC6880809.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    42. Sexual Risk and Criminal Justice Involvement Among Women Who Use Drugs. AIDS Behav. 2019 Dec; 23(12):3366-3374. Knittel AK, Lambdin BH, Comfort ML, Kral AH, Lorvick J. PMID: 30859344; PMCID: PMC6739179.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019 12; 74:299-304. Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. PMID: 31733979; PMCID: PMC6949008.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    44. Overdose Education and Naloxone Distribution in the San Francisco County Jail. J Correct Health Care. 2019 10; 25(4):394-404. Wenger LD, Showalter D, Lambdin B, Leiva D, Wheeler E, Davidson PJ, Coffin PO, Binswanger IA, Kral AH. PMID: 31672075.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    45. Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the RE-AIM Framework. Int J Environ Res Public Health. 2019 02 28; 16(5). Hassan S, Cooke A, Saleem H, Mushi D, Mbwambo J, Lambdin BH. PMID: 30823440; PMCID: PMC6427450.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    46. Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention. Addict Sci Clin Pract. 2019 01 28; 14(1):3. Cooke A, Saleem H, Hassan S, Mushi D, Mbwambo J, Lambdin B. PMID: 30691511; PMCID: PMC6350287.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. The Opioid Epidemic in Africa And Its Impact. Curr Addict Rep. 2018 Dec; 5(4):428-453. Kurth AE, Cherutich P, Conover R, Chhun N, Bruce RD, Lambdin BH. PMID: 32494564; PMCID: PMC7269163.
      View in: PubMed   Mentions: 16  
    48. Exploring Lifetime Accumulation of Criminal Justice Involvement and Associated Health and Social Outcomes in a Community-Based Sample of Women who Use Drugs. J Urban Health. 2018 08; 95(4):584-593. Lorvick J, Comfort M, Kral AH, Lambdin BH. PMID: 29214435; PMCID: PMC6095749.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    49. Accumulation of Jail Incarceration and Hardship, Health Status, and Unmet Health Care Need Among Women Who Use Drugs. Womens Health Issues. 2018 Sep - Oct; 28(5):470-475. Lambdin BH, Comfort M, Kral AH, Lorvick J. PMID: 30061031.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    50. Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addict Behav. 2018 10; 85:94-99. Lorvick J, Browne EN, Lambdin BH, Comfort M. PMID: 29883856.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    51. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States. Drug Alcohol Depend. 2018 07 01; 188:370-376. Lambdin BH, Davis CS, Wheeler E, Tueller S, Kral AH. PMID: 29776688.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    52. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018 11; 86:90-95. McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, Pemberton M, Kral AH. PMID: 29610001.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    53. A Strengths-Based Case Management Intervention to Reduce HIV Viral Load Among People Who Use Drugs. AIDS Behav. 2018 01; 22(1):146-153. Kral AH, Lambdin BH, Comfort M, Powers C, Cheng H, Lopez AM, Murdoch RO, Neilands TB, Lorvick J. PMID: 28916898.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    54. Addressing the Micro- and Macro-Environmental Vulnerabilities to HIV of People Who Inject Drugs in Tanzania: A Case Study of the Muhimbili Medication-Assisted Treatment Clinic. Structural Dynamics of HIV. 2018 Jan 1; 4:45-63. Mbwambo MJ, Saleem SH, Kaduri KP, Lambdin LB, McCurdy MS. .
      View in: Publisher Site   Mentions:
    55. Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Int J Drug Policy. 2018 02; 52:52-55. Lambdin BH, Zibbell J, Wheeler E, Kral AH. PMID: 29232604.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    56. Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania. Addict Sci Clin Pract. 2017 10 18; 12(1):23. Cooke A, Saleem H, Mushi D, Mbwambo J, Hassan S, Lambdin BH. PMID: 29041950; PMCID: PMC5646174.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    57. First Report of Gender Based Violence as a Deterrent to Methadone Access Among Females Who Use Heroin in Dar es Salaam, Tanzania. AIDS Behav. 2017 Jul; 21(7):2093-2100. Balaji D, Mlunde LB, Tran OC, Lambdin B, Mbwambo J, Nyandindi C, Matiko E, Copenhaver M, Douglas Bruce R. PMID: 27752867.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    58. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. Int J Drug Policy. 2017 07; 45:64-69. Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, Kral AH. PMID: 28628854; PMCID: PMC6166640.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    59. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California. Addict Sci Clin Pract. 2017 06 14; 12(1):13. Lambdin BH, Kral AH, Comfort M, Lopez AM, Lorvick J. PMID: 28610602; PMCID: PMC5470222.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    60. Impact of a strengths-based case management intervention on HIV viral load among people who use drugs in Oakland, California. Drug and Alcohol Dependence. 2017 Feb 1; 171:e109-e110. Kral KA, Comfort CM, Powers PC, Cheng CH, Lopez LA, Lambdin LB, Lorvick LJ. .
      View in: Publisher Site   Mentions:
    61. Wait and consult times for primary healthcare services in central Mozambique: a time-motion study. Glob Health Action. 2016; 9:31980. Wagenaar BH, Gimbel S, Hoek R, Pfeiffer J, Michel C, Cuembelo F, Quembo T, Afonso P, Gloyd S, Lambdin BH, Micek MA, Porthé V, Sherr K. PMID: 27580822; PMCID: PMC5007246.
      View in: PubMed   Mentions: 19     Fields:    
    62. Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania. Int J Drug Policy. 2016 Apr; 30:74-81. Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, McCurdy S, Mbwambo J, Lambdin BH. PMID: 27017376; PMCID: PMC4829437.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    63. Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania. Int J Drug Policy. 2016 Apr; 30:43-51. Zamudio-Haas S, Mahenge B, Saleem H, Mbwambo J, Lambdin BH. PMID: 26880500; PMCID: PMC4829444.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    64. "Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania. Int J Drug Policy. 2016 Apr; 30:59-65. Saleem HT, Mushi D, Hassan S, Bruce RD, Cooke A, Mbwambo J, Lambdin BH. PMID: 26831364; PMCID: PMC4829458.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    65. Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania. J Int AIDS Soc. 2015; 18:19936. Lambdin BH, Mbwambo JK, Josiah RM, Bruce RD. PMID: 26202669; PMCID: PMC4511823.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    66. Implementation and Operational Research: Linkage to Care Among Methadone Clients Living With HIV in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2015 Jun 01; 69(2):e43-8. Tran OC, Bruce RD, Masao F, Ubuguyu O, Sabuni N, Mbwambo J, Lambdin BH. PMID: 26009835; PMCID: PMC4435505.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    67. Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs. Curr HIV Res. 2015; 13(3):244-9. Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P. PMID: 25986374; PMCID: PMC4460284.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    68. Avoiding treatment due to fears of violence: The first report of gender-based and intimate partner violence in the community and in the hospital among female heroin users in Dar es Salaam, Tanzania. Drug and Alcohol Dependence. 2015 Jan 1; 146:e214. Balaji BD, Lambdin LB, Mbwambo MJ, Chang CO, Nyandindi NC, Copenhaver CM, Bruce BR. .
      View in: Publisher Site   Mentions:
    69. The SHAZ! project: results from a pilot randomized trial of a structural intervention to prevent HIV among adolescent women in Zimbabwe. PLoS One. 2014; 9(11):e113621. Dunbar MS, Kang Dufour MS, Lambdin B, Mudekunye-Mahaka I, Nhamo D, Padian NS. PMID: 25415455; PMCID: PMC4240618.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    70. Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. Int J Tuberc Lung Dis. 2014 Jul; 18(7):793-8. Gupta A, Mbwambo J, Mteza I, Shenoi S, Lambdin B, Nyandindi C, Doula BI, Mfaume S, Bruce RD. PMID: 24902554; PMCID: PMC4506927.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    71. Prevalence of HIV, hepatitis C and depression among people who inject drugs in the Kinondoni Municipality In Dar Es Salaam, Tanzania. Drug and Alcohol Dependence. 2014 Jul 1; 140:e164. Nyandindi NC, Mbwambo MJ, McCurdy MS, Lambdin LB, Copenhaver CM, Bruce BR. .
      View in: Publisher Site   Mentions:
    72. Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 2014 Sep 01; 59(5):735-42. Lambdin BH, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A, Sabuni N, Bruce RD. PMID: 24855149; PMCID: PMC4809981.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    73. Computerized counseling reduces HIV-1 viral load and sexual transmission risk: findings from a randomized controlled trial. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):611-20. Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK. PMID: 24384803; PMCID: PMC3999203.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsPHPublic Health
    74. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014 Jan; 25(1):22-5. Bruce RD, Lambdin B, Chang O, Masao F, Mbwambo J, Mteza I, Nyandindi C, Zamudio-Haas S, Buma D, Dunbar MS, Kilonzo G. PMID: 24210295.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    75. Identifying programmatic gaps: inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLoS One. 2013; 8(6):e67062. Lambdin BH, Bruce RD, Chang O, Nyandindi C, Sabuni N, Zamudio-Haas S, McCurdy S, Masao F, Ivo Y, Msami A, Ubuguy O, Mbwambo J. PMID: 23825620; PMCID: PMC3692420.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    76. Integration of HIV care and treatment in primary health care centers and patient retention in central Mozambique: a retrospective cohort study. J Acquir Immune Defic Syndr. 2013 Apr 15; 62(5):e146-52. Lambdin BH, Micek MA, Sherr K, Gimbel S, Karagianis M, Lara J, Gloyd SS, Pfeiffer J. PMID: 23288031; PMCID: PMC4551421.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    77. An Overview of HIV Prevention Interventions for People Who Inject Drugs in Tanzania. Adv Prev Med. 2013; 2013:183187. Ratliff EA, McCurdy SA, Mbwambo JK, Lambdin BH, Voets A, Pont S, Maruyama H, Kilonzo GP. PMID: 23346410; PMCID: PMC3549374.
      View in: PubMed   Mentions: 20  
    78. If, when and how to tell: a qualitative study of HIV disclosure among young women in Zimbabwe. Reprod Health Matters. 2012 Dec; 20(39 Suppl):18-26. Zamudio-Haas S, Mudekunye-Mahaka I, Lambdin BH, Dunbar MS. PMID: 23177677.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    79. Track C Epidemiology and Prevention Science. Journal of the International AIDS Society. 2012 Oct 22; 15(Suppl 3):18440-001. Raugi RD, Gottlieb GG, Sow SP, Cherne CS, Toure TM, Sall SF, Traore TF, Sy SM, Zheng ZN, N'Doye NI, Kiviat KN, Hawes HS, Messeri MP, Chiasson CM, Kall KM, Smith SR, Brown BA, Delpech DV, Eritsyan EK, Levina LO, Smolskaia ST, White WE, Heimer HR, de Vos dA, van der Helm vJ, Prins PM, Kretzschmar KM, Hontelez HJ, de Vlas dS, Baltussen BR, Bakker BR, Tanser TF, Lurie LM, Bärnighausen BT, Powers PK, Ghani GA, Miller MW, Hoffman HI, Pettifor PA, Hosseinipour HM, Kamanga KG, Martinson MF, Cohen CM, Dimitrov DD, Boily BM, Marrazzo MJ, Brown BE, Qian QH, Lou LJ, Ruan RY, Webb WG, Shao SY, Vermund VS, Morris MM, Evans EJ, Yu YM, Briceno BA, Page PK, Hahn HJ, Patel PS, Schechter SM, Muyinda MH, Kiwanuka KN, Sewankambo SN, Spittal SP, Fichorova FR, Morrison MC, Doncel DG, Chen CP, Kwok KC, Chipato CT, Salata SR, Mauck MC, Heffron HR, Donnell DD, Rees RH, Celum CC, Mugo MN, Were WE, de Bruyn dG, Nakku-Joloba NE, Ngure NK, Kiarie KJ, Coombs CR, Baeten BJ, Polis PC, Curtis CK, Phillips PS, Curtis CK, Polis PC, Beer BL, Oster OA, Mattson MC, Skarbinski SJ, Kahle KE, Campbell CM, Lingappa LJ, Donnell DD, Celum CC, Kapiga KS, Ondondo OR, Mugo MN, Mujugira MA, Fife FK, Mullins MJ, Baeten BJ, Bearnot BB, Werner WL, Kharsany KA, Karim KS, Frohlich FJ, Karim KQ, Mapanje MC, Rutstein RS, Kamanga KG, Phiri PS, Nsona ND, Pettifor PA, Rosenberg RN, Hoffman HI, Miller MW, Crane CH, Mimiaga MM, Feldman FB, Fredericksen FR, Mugavero MM, Willig WJ, Safren SS, Matthews MW, Christopoulos CK, Boswell BS, Kitahata KM, Saag SM, Mayer MK, Hesseling HA, Passmore PJ, Gamieldien GH, Jones JC, Hanekom HW, Sodora SD, Jaspan JH, Hall HH, Frazier FE, Rhodes RP, Holtgrave HD, Furlow-Parmley FC, Tang TT, Gray GK, Cohen CS, Skarbinski SJ, Fishel FJ, Bradley BS, Young YP, Mbofana MF, Botao BC, Zaidi ZJ, Grapsa GE, Tanser TF, Newell NM, Bärnighausen BT, Van Renterghem VH, Colvin CM, de Beer dI, Gunthorp GJ, Odiit OM, Thomas TL, Jackson JH, Getahun GM, Grady GB, van der Knaap vN, van der Loeff vM, Heijman HT, Speksnijder SA, Geskus GR, Prins PM, Meade MC, Watt WM, Sikkema SK, Deng DL, Ranby RK, Skinner SD, Pieterse PD, Kalichman KS, Peinado PJ, Lama LJ, Gonzales GP, Cabello CR, Rosas RG, Sanchez SJ, Cao CX, Wu WZ, Rou RK, Pang PL, Baral BS, Beyrer BC, Muessig MK, Poteat PT, Wirtz WA, Decker DM, Sherman SS, Kerrigan KD, Shannon SK, Akello AM, Muldoon MK, Simo SA, Muzaaya MG, Rosenberg RE, Kelley KC, O'Hara OB, Frew FP, Peterson PJ, Sanchez ST, del Rio dC, Sullivan SP, Oster OA, Russell RK, Wiegand WR, Le LB, Valverde VE, Forrest FD, Cribbin CM, Paz-Bailey PG, Oster OA, Johnson JC, Le LB, Finlayson FT, Balaji BA, Lansky LA, Mermin MJ, Valleroy VL, MacKellar MD, Behel BS, Paz-Bailey PG, Mayer MK, Wang WL, Koblin KB, Mao MC, Mannheimer MS, Magnus MM, del Rio dC, Buchbinder BS, Wilton WL, Cummings CV, Watson WC, Griffith GS, Wheeler WD, Koblin KB, Mayer MK, Eshleman ES, Wang WL, Shoptaw SS, del Rio dC, Buchbinder BS, Magnus MM, Mannheimer MS, Liu LT, Cummings CV, Piwowar-Manning PE, Fields FS, Griffith GS, Elharrar EV, Wheeler WD, Mellouk MO, Alami AK, Rhilani RH, Rafif RN, Abadie AA, Ouarsas OL, Bennani BA, Omari OB, Oumzil OI, Johnston JL, Rangsin RR, Kana KK, Chuenchitra CT, Sunantarod SA, Meesiri MS, Areekul AW, Nelson NK, Khobragade KS, Goswami GP, Ramakrishnan RL, George GB, Adhikary AR, Ramanathan RS, Mathew MS, Kumar KR, Kodali KV, Wirtz WA, Trapence TG, Jumbe JV, Umar UE, Ketende KS, Kamba KD, Berry BM, Stromdahl SS, Beyrer BC, Baral BS, Metsch ML, Kuo KI, Lalota LM, Phillips PG, Cardenas CG, Castel CA, Forrest FD, West WT, Pereyra PM, Jia JY, Kolber KM, Opoku OJ, Magnus MM, Elkamhawi ES, Abaza AO, Elghamrawy EE, Elmagd ES, Ramy RH, Atallah AS, Elkot EN, Kamal KM, Mawazini MF, Helmy HR, Soliman SC, Pharris PA, Noori NT, Likatavicius LG, van de Laar vM, Baral BS, Poteat PT, Wirtz WA, Stromdahl SS, Beyrer BC, Okuku OH, Wahome WE, Duncan DS, Thiongo’ TA, Mwambi MJ, Shafi SJ, Smith SA, Graham GS, et al. .
      View in: Publisher Site   Mentions:
    80. An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique. BMC Health Serv Res. 2012 Feb 02; 12:30. Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, Karagianis M, Lara J, Gloyd SS, Stergachis A. PMID: 22296979; PMCID: PMC3293775.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    81. Drug trafficking, use, and HIV risk: the need for comprehensive interventions. SAHARA J. 2012; 9(3):154-9. Mbwambo J, McCurdy SA, Myers B, Lambdin B, Kilonzo GP, Kaduri P. PMID: 23237070.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    82. Local residents trained as 'influence agents' most effective in persuading African couples on HIV counseling and testing. Health Aff (Millwood). 2011 Aug; 30(8):1488-97. Lambdin BH, Kanweka W, Inambao M, Mwananyanda L, Shah HD, Linton S, Wong F, Luisi N, Tichacek A, Kalowa J, Chomba E, Allen S. PMID: 21821565; PMCID: PMC3503238.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    83. Patient volume, human resource levels, and attrition from HIV treatment programs in central Mozambique. J Acquir Immune Defic Syndr. 2011 Jul 01; 57(3):e33-9. Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, Karagianis M, Lara J, Gloyd SS, Stergachis A. PMID: 21372723; PMCID: PMC4551473.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    84. An assessment of routine primary care health information system data quality in Sofala Province, Mozambique. Popul Health Metr. 2011 May 13; 9:12. Gimbel S, Micek M, Lambdin B, Lara J, Karagianis M, Cuembelo F, Gloyd SS, Pfeiffer J, Sherr K. PMID: 21569533; PMCID: PMC3112390.
      View in: PubMed   Mentions: 54     Fields:    
    85. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case study. J Int AIDS Soc. 2010 Jan 20; 13:3. Pfeiffer J, Montoya P, Baptista AJ, Karagianis M, Pugas Mde M, Micek M, Johnson W, Sherr K, Gimbel S, Baird S, Lambdin B, Gloyd S. PMID: 20180975; PMCID: PMC2828398.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    86. Dry season production of filariasis and dengue vectors in American Samoa and comparison with wet season production. Am J Trop Med Hyg. 2009 Dec; 81(6):1013-9. Lambdin BH, Schmaedick MA, McClintock S, Roberts J, Gurr NE, Marcos K, Waller L, Burkot TR. PMID: 19996430; PMCID: PMC4560171.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    87. Utilization of domestic and natural containers by Aedes oceanicus in American Samoa. J Med Entomol. 2008 Jul; 45(4):758-62. Lambdin B, Schmaedick MA, Burkot TR. PMID: 18714880.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    88. Utilization of Domestic and Natural Containers by Aedes oceanicus in American Samoa. Journal of Medical Entomology. 2008 Jul 1; 45(4):758-762. Lambdin LB, Schmaedick SM, Burkot BT. .
      View in: Publisher Site   Mentions:
    89. Utilization of Domestic and Natural Containers by Aedes oceanicus in American Samoa. Journal of Medical Entomology. 2008 Jul 1; 45(4):758-762. Lambdin LB, Schmaedick SM, Burkot BT. .
      View in: Publisher Site   Mentions:
    90. Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One. 2008 Jan 09; 3(1):e1411. Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, Kanweka W, Allen S, Kiarie JN, Makhema J, Were E, Manongi R, Coetzee D, de Bruyn G, Delany-Moretlwe S, Magaret A, Mugo N, Mujugira A, Ndase P, Celum C, Partners in Prevention HSV-2/HIV Transmission Study Group. PMID: 18183292; PMCID: PMC2156103.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCTClinical Trials
    Barrot's Networks
    Concepts (214)
    Derived automatically from this person's publications.
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _